EUVIMEDEUVIMED entdecken
Crossref

Customizable Glycopolymers as Adjuvants for Cancer Immunotherapy: From Branching Degree Optimization to Cell Surface Engineering

Zhichen Zhu, Xingyu Heng, Fangjian Shan, He Yang iD, Yichen Wang, Hengyuan Zhang, Gaojian Chen iD, Hong Chen iD

Biomacromolecules · 09.12.2024 · 25 (12) · 7975-7984

DOI: 10.1021/acs.biomac.4c01230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, online erschienen am 13.11.2024. Verfasst von Zhichen Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, Jiangsu Key Laboratory of Advanced Functional Polymer Material…. Hauptthemen laut MEDLINE: Dendritic Cells, Immunotherapy, Neoplasms, Adjuvants, Immunologic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineering dendritic cell (DC) maturation is paramount for robust T-cell responses and immunological memory, critical for cancer immunotherapy. This work unveils a novel strategy using precisely controlled branching in synthetic glycopolymers to optimize DC activation. Using the distinct copolymerization kinetics of 2-(methacrylamido) glucopyranose (MAG) and diethylene glycol dimethacrylate (DEGDMA) in a RAFT polymerization, unique glycopolymers with varying branching degrees are created. These strategically produced gradient branched glycopolymers with sugar moieties on the outer chain potently promote DC maturation. Strikingly, low-branched glycopolymers demonstrate superior activity, both in pure form and when engineered on tumor cell surfaces. Quartz crystal microbalance and theoretical simulations elucidate the crucial role of branching in modulating glycopolymer-DC receptor interactions. Low-branched gradient glycopolymers have shown a notable advantage and are promising adjuvants in DC-based cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsImmunotherapyNeoplasmsAdjuvants, ImmunologicHumansPolymersPolymerizationCell EngineeringAnimals

Substanzen

Adjuvants, ImmunologicPolymers

Autor:innen und Institutionen

  • State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, Jiangsu Key Laboratory of Advanced Functional Polymer Materials, College of Chemistry, Chemical Engineering and Materials Science, S…

ORCID-Profile: He Yang, Gaojian Chen, Hong Chen

Förderung

  • National Natural Science Foundation of China
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Zhu, Z., Heng, X., Shan, F., Yang, H., Wang, Y., Zhang, H., Chen, G., & Chen, H. (2024). Customizable Glycopolymers as Adjuvants for Cancer Immunotherapy: From Branching Degree Optimization to Cell Surface Engineering. Biomacromolecules, 25(12), 7975-7984. https://doi.org/10.1021/acs.biomac.4c01230

Vancouver

Zhu Z, Heng X, Shan F, Yang H, Wang Y, Zhang H, et al. Customizable Glycopolymers as Adjuvants for Cancer Immunotherapy: From Branching Degree Optimization to Cell Surface Engineering. Biomacromolecules. 2024;25(12):7975-7984. doi:10.1021/acs.biomac.4c01230

BibTeX
@article{Zhu2024,
  author = {Zhu, Zhichen and Heng, Xingyu and Shan, Fangjian and Yang, He and Wang, Yichen and Zhang, Hengyuan and Chen, Gaojian and Chen, Hong},
  title = {Customizable Glycopolymers as Adjuvants for Cancer Immunotherapy: From Branching Degree Optimization to Cell Surface Engineering},
  journal = {Biomacromolecules},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {7975--7984},
  doi = {10.1021/acs.biomac.4c01230}
}
Kostenlos starten →